Drug
LITFULO
LITFULO is a pharmaceutical drug with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph phase_2
1
33%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution1 total trials
Phase 2Efficacy & side effects
1(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Recruiting1
Active, not recruiting1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 21 (100.0%)
Trials by Status
recruiting133%
active_not_recruiting133%
not_yet_recruiting133%
Recent Activity
2 active trials
Showing 3 of 3
not_yet_recruitingphase_2
Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo
NCT07152626
active_not_recruiting
Litfulo Capsules Special Investigation
NCT06279221
recruiting
A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.
NCT07152119
Clinical Trials (3)
Showing 3 of 3 trials
NCT07152626Phase 2
Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo
NCT06279221
Litfulo Capsules Special Investigation
NCT07152119
A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3